Cancer Research Institute (CRI) shared on LinkedIn:
“CRI is proud to introduce the Fall 2025 and Spring 2026 classes of CRI Irvington Postdoctoral Fellows and Immuno-Informatics Postdoctoral Fellows!
These outstanding scientists are advancing innovative research spanning tumor immunology, computational biology, cellular engineering, and other emerging frontiers that will help shape the next generation of cancer immunotherapies.
‘Postdocs are the invisible engine of biomedical discovery,‘ says Dr. Miriam Merad, Associate Director of CRI’s Scientific Advisory Council.
‘At a time when federal support is faltering, CRI is once again stepping up. Supporting these young scientists is not just an act of resilience; it’s a commitment to the future of science and the patients who depend on it.’
Join us in celebrating the remarkable scientists who are helping build a world immune to cancer: The Future Starts Here: Meet the 2025–2026 Postdoctoral Fellows.”
Other articles about Cancer Research Institute on OncoDaily.